We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Zoo Digital Group Plc | LSE:ZOO | London | Ordinary Share | GB00B1FQDL10 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.50 | 1.35% | 37.50 | 37.00 | 38.00 | 37.50 | 36.50 | 36.50 | 462,824 | 09:49:04 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Computers & Software-whsl | 90.26M | 8.23M | 0.0841 | 4.46 | 36.69M |
Date | Subject | Author | Discuss |
---|---|---|---|
12/12/2019 07:50 | I wonder what that's about. If they exit entirely the share price will get crushed. But perhaps its just a reduction as a result of investor outflows or portfolio restructuring. Hard to say for outsiders. | tkamp | |
12/12/2019 07:24 | RNS Invesco dispose of 2.24% - explains drop in share price yesterday. | uknighted | |
10/12/2019 22:34 | Just in case it has been missed from the Zoo news. hxxps://www.zoodigit | plok | |
05/12/2019 15:11 | For Invesco read Oppenheimer - they bought them last May. So same stake, no change. Update! Actually, they've reduced by 2.5m. Held 14m at the end of May. | rambutan2 | |
05/12/2019 14:46 | Yes I think you are right an increase of circa 87k - 74,424,771 in May 74,512,271 today | simonp | |
05/12/2019 14:38 | My reading, for what it is worth, is that Invesco have bought, not sold, shares. | uknighted | |
05/12/2019 14:10 | They may have dumped 2.5m but someone bought them and the price hasn't moved much so that's got to be positive | simonp | |
05/12/2019 13:59 | invesco dumped nearly 2.5 million shsres as per rns today | aphzombie | |
02/12/2019 16:53 | 500,000 shares in one trade on Friday last. A 450,000 trade today and a 1,500,000 trade today. This is not normal for Zoo. NIA and DYOR | martina pescatore | |
28/11/2019 08:44 | Interesting article in the news section on zoo website... Case Study – The Bletchley Circle: San Francisco | How scripting can make or break localization for simultaneous global release Tuesday, November 26, 2019 | martina pescatore | |
13/11/2019 15:14 | We need to be a preferred provider to more than Disney imo. Further wins would help. | gerihatrick | |
13/11/2019 08:35 | If there was still any doubt about who the 'major OTT' is where Zoo has won Primary Partner status Stuart's post on LinkedIn yesterday on the launch of Disney+ should take away any last concerns... | tkamp | |
12/11/2019 21:21 | Here’s zoo’s tweet on the subject: Massive congrats to our friends at @Disney on the ground-breaking launch of @disneyplus! 🎉 With all this fresh content, what will you be diving into first? | uknighted | |
11/11/2019 18:21 | Lots of excitement about Disney Plus that launches tomorrow, let’s hope that Zoo get a chunk of the business on offer. | plok | |
07/11/2019 11:41 | ZOO Digital H1 19 investor presentation by CEO&CFO. Won a major OTT provider in period, providing better rev visibility going forward. Things panning out nicely. | tomps2 | |
04/11/2019 09:55 | @owensk, It's actually the exact opposite. It's clear how Zoo makes money, it's less clear why demand for its services isn't coming through more strongly... | tkamp | |
04/11/2019 08:52 | Share price needs to come back to reality, this outfit was always banging on about how good they were at saving customers money but a bit scant on how they made money. Today's news just confirms that. imo | owenski | |
04/11/2019 08:49 | It just needs to start delivering. If you look high level... they have ramped up Netflix, launched a dubbing service, launched Zoo studio, and started to do work with Disney... and yet its sales growth hasn't been impressive. There are more negatives offsetting these positives we arnt being made aware of. | brokenbuckles | |
04/11/2019 07:47 | Results day in Zoo tend to be bad days, it's when they confirm again how crazily overvalued this stock is. | dave4545 | |
04/11/2019 07:44 | @Brokenbuckles I imagine Zoo's management will be a bit more cautious about market expectations running very high again. After the previously extremely volatile share price driven by poor investor-communicati For me the communication is neutral. We already knew that H1 revenue would be slightly down, and profits up. The fact that they finally confirm they are a primary vendor for Disney is a positive, and that some 'major media' company has adopted ZooStudio is a positive as well. The outlook is fairly light on details but that's often the case with Zoo, and probably also the right thing for management to do. | tkamp | |
04/11/2019 07:34 | So no change to expectations even though they won all this Disney work? Doesnt make sense? | brokenbuckles | |
04/11/2019 07:17 | Bit overvalued this isn't it? | owenski | |
27/10/2019 16:37 | Please see SKIN - about to move up. 1) Laboratory grown human skin that can be tested on, instead of testing on animals 2) Only commercially available option of its type. 3) Exploiting high growth technologies such as Artificial Intelligence 4) Human skin cloning duplicates test subjects 5) It is an Ethical investment 6) Exploiting CBD market 7) Cutting edge Woundcare -Visual diagnostic wound dressing that changes colour to indicate infection or improvement of the wound under the dressing. 8) Expanding laboratory space by 100% to accommodate the rate of growth due to be RNS any day 9) Currently negotiating further contracts. (8 CBD we know of and others) due to be RNS soon 10) Fully funded - The growth of the Company has been so well supported and received by the market that all corporate activity has been achieved, funding in place to accommodate the continued growth. 11) Meeting its objective of increasing the average revenue per client as it evolves into a multiple revenue stream product and services company 12) Four Blue-Chip (US and EU) client agreements signed 13) owns 9.35% of Cellulac plc 14) Algzym - A patented enzyme-based technology which bursts algal cell walls and releases Omega 3 oils in a simple solvent-free process. 15) Company moving forward at a rapid pace. 16) Major relationships already built with billion-dollar companies 17) Sales routes for products already in place in multiple countries 18) EU laws changing to force companies to stop beauty and pharmaceuticals testing on animals. 19) EU laws changing to force companies to stop making claims they can't back up scientifically. 20) EU laws changing to force companies to comply with more rigorous testing before market launch. 21) Presenting at major US and European Skin and Dermatology events 22) Presenting at major CBD Exhibitions 23) Strong, dynamic and driven board 24) CEO is an owner of company/major investor The chart is primed for a great entry' | lisae123 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions